213 related articles for article (PubMed ID: 20865150)
1. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
[TBL] [Abstract][Full Text] [Related]
2. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
[TBL] [Abstract][Full Text] [Related]
3. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.
Nicastro G; Masino L; Esposito V; Menon RP; De Simone A; Fraternali F; Pastore A
Biopolymers; 2009 Dec; 91(12):1203-14. PubMed ID: 19382171
[TBL] [Abstract][Full Text] [Related]
4. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions as a survival strategy against abnormal aggregation.
Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.
Weeks SD; Grasty KC; Hernandez-Cuebas L; Loll PJ
J Biol Chem; 2011 Feb; 286(6):4555-65. PubMed ID: 21118805
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
[TBL] [Abstract][Full Text] [Related]
9. Proteotoxic stress increases nuclear localization of ataxin-3.
Reina CP; Zhong X; Pittman RN
Hum Mol Genet; 2010 Jan; 19(2):235-49. PubMed ID: 19843543
[TBL] [Abstract][Full Text] [Related]
10. Structure validation of the Josephin domain of ataxin-3: conclusive evidence for an open conformation.
Nicastro G; Habeck M; Masino L; Svergun DI; Pastore A
J Biomol NMR; 2006 Dec; 36(4):267-77. PubMed ID: 17096206
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.
Winborn BJ; Travis SM; Todi SV; Scaglione KM; Xu P; Williams AJ; Cohen RE; Peng J; Paulson HL
J Biol Chem; 2008 Sep; 283(39):26436-43. PubMed ID: 18599482
[TBL] [Abstract][Full Text] [Related]
12. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.
Nicastro G; Menon RP; Masino L; Knowles PP; McDonald NQ; Pastore A
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10493-8. PubMed ID: 16020535
[TBL] [Abstract][Full Text] [Related]
13. Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes.
Tzvetkov N; Breuer P
Biol Chem; 2007 Sep; 388(9):973-8. PubMed ID: 17696782
[TBL] [Abstract][Full Text] [Related]
14. The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils.
Masino L; Nicastro G; De Simone A; Calder L; Molloy J; Pastore A
Biophys J; 2011 Apr; 100(8):2033-42. PubMed ID: 21504740
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3.
Chow MK; Mackay JP; Whisstock JC; Scanlon MJ; Bottomley SP
Biochem Biophys Res Commun; 2004 Sep; 322(2):387-94. PubMed ID: 15325242
[TBL] [Abstract][Full Text] [Related]
16. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis.
Williams AJ; Knutson TM; Colomer Gould VF; Paulson HL
Neurobiol Dis; 2009 Mar; 33(3):342-53. PubMed ID: 19084066
[TBL] [Abstract][Full Text] [Related]
17. Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117.
Todi SV; Scaglione KM; Blount JR; Basrur V; Conlon KP; Pastore A; Elenitoba-Johnson K; Paulson HL
J Biol Chem; 2010 Dec; 285(50):39303-13. PubMed ID: 20943656
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
19. CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.
Mueller T; Breuer P; Schmitt I; Walter J; Evert BO; Wüllner U
Hum Mol Genet; 2009 Sep; 18(17):3334-43. PubMed ID: 19542537
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Matos CA; de Macedo-Ribeiro S; Carvalho AL
Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
